• C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 20 Dec 2024 05:02:11   America/Chicago


    C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Shares of C4 Therapeutics, Inc.
    Read more...
Share on,